John S. Wesolowski
- Radiology, Nuclear Medicine and Imaging top 5%
- Molecular Biology
- Immunology top 10%
- Oncology top 10%
- Neurology
- Co-authors
- Stephen D. GilliesSylvia A. HoldenMichael SuperLan YanKin-Ming LoVanita D. SoodRalph A. ReisfeldRobertson Parkman
- Topics
- Monoclonal and Polyclonal Antibodies Research (13 papers)Glycosylation and Glycoproteins Research (6 papers)Radiopharmaceutical Chemistry and Applications (4 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
John S. Wesolowski
21 papers receiving 635 citations
Peers
Comparison fields: 5 of 73
- Radiology, Nuclear Medicine and Imaging 371
- Molecular Biology 311
- Immunology 238
- Oncology 233
- Neurology 74
Countries citing papers authored by John S. Wesolowski
This map shows the geographic impact of John S. Wesolowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Wesolowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Wesolowski more than expected).
Fields of papers citing papers by John S. Wesolowski
This network shows the impact of papers produced by John S. Wesolowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Wesolowski. The network helps show where John S. Wesolowski may publish in the future.
Co-authorship network of co-authors of John S. Wesolowski
This figure shows the co-authorship network connecting the top 25 collaborators of John S. Wesolowski. A scholar is included among the top collaborators of John S. Wesolowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Wesolowski. John S. Wesolowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 34 | |
| 3 | 73 | |
| 4 | 19 | |
| 5 | 16 | |
| 6 | 44 | |
| 7 | 4 | |
| 8 | Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents. | 45 |
| 9 | Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors. | 37 |
| 10 | 78 | |
| 11 | 35 | |
| 12 | 11 | |
| 13 | 13 | |
| 14 | 9 | |
| 15 | 40 | |
| 16 | 130 | |
| 17 | 28 | |
| 18 | 16 | |
| 19 | 18 | |
| 20 | 10 |
About John S. Wesolowski
John S. Wesolowski is a scholar working on Radiology, Nuclear Medicine and Imaging, Transplantation and Immunology, having authored 21 papers that have together received 670 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (6 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (371 citations), Immunology (238 citations) and Oncology (233 citations). John S. Wesolowski has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Stephen D. Gillies, Sylvia A. Holden, Michael Super, Lan Yan, Kin-Ming Lo, Vanita D. Sood, Ralph A. Reisfeld, Robertson Parkman, Yan Lan and Christie Kelton. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.